Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $808.67, a high ...

Initial results show a 17x increase in processing speed using NVIDIA H100 GPUs on NVIDIA DGX CloudParis, France – June xx 2025 – Cure51, the Techbio company on a mission to decode the biology of ...

Guangzhou Pharmaceutical Holdings Limited (GPHL), a Fortune Global 500 company, has taken a significant step forward in its ...

After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...

Hedge funds revealed their top investment ideas, from Chinese self-driving taxis to an Indian drug retailer, at the annual ...

Berlin: Bayer has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products ...

CRL and CHDI Foundation extend their Huntington's disease partnership, boosting integration and global flexibility in drug discovery.

Elsewhere in Southeast Asia, the Thai baht strengthened 0.09% against the dollar to 32.59, while the Singapore dollar shed ...

Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to ...

The need for laparoscopic devices is predicted to rise at a sluggish CAGR of 4.2% through 2034. The industry is projected to surpass USD 20.5 billion by 2034. The surge in the prevalence of obesity ...

Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously iterating that low ...